Literature DB >> 10190561

Potency of dietary indole-3-carbinol as a promoter of aflatoxin B1-initiated hepatocarcinogenesis: results from a 9000 animal tumor study.

A Oganesian1, J D Hendricks, C B Pereira, G A Orner, G S Bailey, D E Williams.   

Abstract

Indole-3-carbinol (I3C), a metabolite of glucobrassicin found in cruciferous vegetables, is documented as acting as a modulator of carcinogenesis and, depending on timing and dose of administration, it may promote hepatocarcinogenesis in some animal models. In this study we demonstrate that, when given post-initiation, dietary I3C promotes aflatoxin B1 (AFB1)-induced hepatocarcinogenesis in the rainbow trout model at levels as low as 500 p.p.m. Trout embryos (approximately 9000) were initiated with 0, 25, 50, 100, 175 or 250 p.p.b. AFB1 by a 30 min immersion. Experimental diets containing 0, 250, 500, 750, 1000 or 1250 p.p.m. I3C were administered starting at 3 months and fish were sampled for liver tumors at 11-13 months. Promotion at the level of tumor incidence was statistically significant for all dietary levels, except 250 p.p.m. Relative potency for promotion markedly increased at dietary levels >750 p.p.m. We propose that more than one mechanism could be involved in promotion and that both estrogenic and Ah receptor-mediated pathways could be active. The estrogenicity of I3C, measured as its ability to induce vitellogenin (an estrogen biomarker in oviparous vertebrates) was evident at the lowest dietary level (250 p.p.m.), whereas CYPIA (a P450 isozyme induced through the Ah receptor pathway) was not induced until dietary levels of 1000 p.p.m. Therefore, at lower dietary levels, promotion by I3C in this model could be explained by estrogenic activities of I3C acid derivatives, as it is known that estrogens promote hepatocarcinogenesis in trout. Much stronger promotion was observed at high dietary I3C levels (1000 and 1250 p.p.m.), at which levels both CYP1A and vitellogenin were induced.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10190561     DOI: 10.1093/carcin/20.3.453

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

Review 1.  Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics.

Authors:  Fazlul H Sarkar; Yiwei Li
Journal:  Cancer Treat Rev       Date:  2009-08-05       Impact factor: 12.111

Review 2.  Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation.

Authors:  Troy D Hubbard; Iain A Murray; Gary H Perdew
Journal:  Drug Metab Dispos       Date:  2015-06-03       Impact factor: 3.922

3.  Intranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailability.

Authors:  Jung Min Song; Ameya R Kirtane; Pramod Upadhyaya; Xuemin Qian; Silvia Balbo; Fitsum Teferi; Jayanth Panyam; Fekadu Kassie
Journal:  Int J Pharm       Date:  2014-10-11       Impact factor: 5.875

Review 4.  The rainbow trout liver cancer model: response to environmental chemicals and studies on promotion and chemoprevention.

Authors:  David E Williams
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-06-16       Impact factor: 3.228

Review 5.  Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis.

Authors:  Jane V Higdon; Barbara Delage; David E Williams; Roderick H Dashwood
Journal:  Pharmacol Res       Date:  2007-01-25       Impact factor: 7.658

6.  The role of estrogen receptor β in transplacental cancer prevention by indole-3-carbinol.

Authors:  Abby D Benninghoff; David E Williams
Journal:  Cancer Prev Res (Phila)       Date:  2013-02-27

Review 7.  Targeting Dietary and Microbial Tryptophan-Indole Metabolism as Therapeutic Approaches to Colon Cancer.

Authors:  Madhur Wyatt; K Leigh Greathouse
Journal:  Nutrients       Date:  2021-04-03       Impact factor: 5.717

8.  Genomic profiling reveals an alternate mechanism for hepatic tumor promotion by perfluorooctanoic acid in rainbow trout.

Authors:  Susan C Tilton; Gayle A Orner; Abby D Benninghoff; Hillary M Carpenter; Jerry D Hendricks; Cliff B Pereira; David E Williams
Journal:  Environ Health Perspect       Date:  2008-08       Impact factor: 9.031

9.  Mechanisms and therapeutic implications of cell death induction by indole compounds.

Authors:  Aamir Ahmad; Wael A Sakr; Km Wahidur Rahman
Journal:  Cancers (Basel)       Date:  2011-07-19       Impact factor: 6.639

Review 10.  Nutritional Therapy to Modulate Tryptophan Metabolism and Aryl Hydrocarbon-Receptor Signaling Activation in Human Diseases.

Authors:  Mohammed Ghiboub; Charlotte M Verburgt; Bruno Sovran; Marc A Benninga; Wouter J de Jonge; Johan E Van Limbergen
Journal:  Nutrients       Date:  2020-09-17       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.